Low Risk of Stroke After Peripheral Vestibular Disorder

This article originally appeared here.
Share this content:
Low Risk of Stroke After Peripheral Vestibular Disorder
Low Risk of Stroke After Peripheral Vestibular Disorder

MONDAY, Sept. 28, 2015 (HealthDay News) -- The risk of stroke is low following emergency department discharge with a diagnosis of peripheral vestibular disorder; however, some strokes are being misdiagnosed as peripheral vestibular disorders, according to a study published online Sept. 18 in the Annals of Neurology.

Clare L. Atzema, M.D., from the University of Toronto, and colleagues conducted a population-based study involving all adult patients discharged from an emergency department with a primary diagnosis of peripheral vestibular disorder. Hospitalized strokes were assessed at seven, 30, 90, and 365 days, as were subsequent falls, motor vehicle accidents, fractures, and burns. The same outcomes were examined in propensity score-matched discharged emergency department patients with renal colic.

The researchers found that 0.18 percent of the 41,794 qualifying patients had a stroke within 30 days. At 30 days, accidental injury ranged from 0.01 percent for falls to 0.15 percent for fractures. Compared with matched renal controls, the relative risk of 30-day stroke was 9.3 times higher. The highest relative risk was seen at seven days (50.0) and it decreased with duration from emergency department visit (relative risks, 6.1 and 2.5 at 90 and 365 days, respectively). The risk of accidental injury did not differ.

"The frequency of early stroke following discharge from an emergency department with a diagnosis of a peripheral vestibular disorder was extremely low," the authors conclude. "However, the relative risk was markedly higher than in matched patients with renal colic, suggesting that some strokes, or sentinel events for strokes, are being misdiagnosed as peripheral vestibular disorders."

Abstract
Full Text (subscription or payment may be required)

Share this content:

is free, fast, and customized just for you!




Already a member?

Sign In Now »

Trending Activities

All Professions

Drug Lookup

Browse drugs by: BrandGenericDisease

More in Home

FDA Permits Marketing of Brain Stimulation Device for OCD

FDA Permits Marketing of Brain Stimulation Device for ...

FDA previously approved transcranial magnetic stimulation for major depression, certain migraines

Comments Open on End of NIH Review for Gene Therapy Studies

Comments Open on End of NIH Review for ...

NIH oversight panel no longer plans to review all applications for gene therapy experiments

U.S. Measles Outbreak Hits 107 Cases in 21 States, D.C.

U.S. Measles Outbreak Hits 107 Cases in 21 ...

Outbreak on track to exceed last year's; most of the people who got measles weren't vaccinated

is free, fast, and customized just for you!




Already a member?

Sign In Now »